{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:40:54Z","timestamp":1773722454650,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.intimp.2008.06.009","type":"journal-article","created":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T01:05:59Z","timestamp":1216170359000},"page":"1533-1539","source":"Crossref","is-referenced-by-count":37,"title":["Enhancement of anti-inflammatory property of aspirin in mice by a nano-emulsion preparation"],"prefix":"10.1016","volume":"8","author":[{"given":"Balajikarthick","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fonghsu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Earl","family":"Ada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Kotyla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subbiah","family":"Yoganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2008.06.009_bib1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2008.06.009_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)01828-9","article-title":"Anti-inflammatory effects of aspirin and sodium salicylate","volume":"447","author":"Amann","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.intimp.2008.06.009_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/1359-6101(96)00020-2","article-title":"Biological and biochemical inhibitors of the NF-kappa B\/Rel proteins and cytokine synthesis","volume":"7","author":"Beauparlant","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3A","key":"10.1016\/j.intimp.2008.06.009_bib4","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of nonsteroidal anti-inflammatory drugs","volume":"104","author":"Vane","year":"1998","journal-title":"Am J Med"},{"issue":"5\u20136","key":"10.1016\/j.intimp.2008.06.009_bib5","first-page":"273","article-title":"Control of COX-2 and iNOS gene expressions by aspirin and salicylate","volume":"110","author":"Kenneth","year":"2003","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.intimp.2008.06.009_bib6","first-page":"624","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"Kenneth","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.intimp.2008.06.009_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.amjcard.2005.06.011","article-title":"Bleeding complications related to aspirin dose","volume":"96","author":"Laine","year":"2005","journal-title":"Am J Cardiol"},{"issue":"7571","key":"10.1016\/j.intimp.2008.06.009_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.38947.697558.AE","article-title":"Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case\u2013control study","volume":"333","author":"Hallas","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.intimp.2008.06.009_bib9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.251.6.754","article-title":"Reye's syndrome associated with long-term aspirin therapy","volume":"251","author":"Young","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2008.06.009_bib10","doi-asserted-by":"crossref","unstructured":"Mina Alfred A, Knipfer, John F, Park, David Y, Bair, Holly A, MSN, Howells, Greg, A., Bendick, Phillip J. Intracranial Complications of Preinjury Anticoagulation in Trauma Patients with Head Injury. J Trauma 2002; Oct 53(4): 668\u2013672.","DOI":"10.1097\/00005373-200210000-00008"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2008.06.009_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2005.11.030","article-title":"Gaultherin, a natural salicylate derivative from Gaultheria yunnanensis: towards a better non-steroidal anti-inflammatory drug","volume":"530","author":"Zhang","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.intimp.2008.06.009_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/01.all.0000235899.57182.d4","article-title":"Genetic mechanism of aspirin-induced urticaria\/angioedema","volume":"6","author":"Kim","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2008.06.009_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(24)34934-1","article-title":"Rofecoxib [Vioxx, MK-0966; 4-(4\u2032-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles","volume":"290","author":"Chan","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.intimp.2008.06.009_bib14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.intimp.2008.06.009_bib15","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/jm0510474","article-title":"Synthesis and structure\u2013activity relationship studies of 1, 3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases","volume":"49","author":"Rao","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.intimp.2008.06.009_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2006.07.054","article-title":"Design of a transdermal delivery system for aspirin as an antithrombotic drug","volume":"327","author":"Ammar","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.intimp.2008.06.009_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cis.2006.05.014","article-title":"Microemulsions as transdermal drug delivery vehicles","volume":"123\u2013126","author":"Kogan","year":"2006","journal-title":"Adv Colloid Interface Sci"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2008.06.009_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2005.05.036","article-title":"Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate","volume":"301","author":"Yamaguchi","year":"2005","journal-title":"Int J Pharm"},{"issue":"9\u201310","key":"10.1016\/j.intimp.2008.06.009_bib19","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1166\/jnn.2006.440","article-title":"Improved oral delivery of paclitaxel following administration in nanoemulsion formulations","volume":"6","author":"Tiwari","year":"2006","journal-title":"J Nanosci Nanotechnol"},{"issue":"8","key":"10.1016\/j.intimp.2008.06.009_bib20","first-page":"554","article-title":"Compariosn of oil-in-water emulsions manufactured by microfluidization and homogenization","volume":"58","author":"Pinnamaneni","year":"2003","journal-title":"Pharmazie"},{"issue":"9","key":"10.1016\/j.intimp.2008.06.009_bib21","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1021\/ja077388j","article-title":"Self delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection","volume":"130","author":"Janjic","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.intimp.2008.06.009_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cis.2003.10.023","article-title":"Formation and stability of nano-emulsions","volume":"108\u2013109","author":"Tadros","year":"2004","journal-title":"Adv Colloid Interface Sci"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2008.06.009_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2004.05.016","article-title":"Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimization","volume":"280","author":"Bouchemal","year":"2004","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.intimp.2008.06.009_bib24","first-page":"129","article-title":"Thomas Shea and Robert Nicolosi. A nanoemulsion of an anti oxidant synergy formulation reduces tumor growth rate in neuroblastoma-bearing mice","volume":"6","author":"Kuo","year":"2007","journal-title":"J Exp Ther Oncol"},{"issue":"6","key":"10.1016\/j.intimp.2008.06.009_bib25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/1523-1747.ep12383512","article-title":"Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin","volume":"102","author":"Wilmer","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2008.06.009_bib26","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1007\/BF01778311","article-title":"Time-dependent cytokine production in the croton oil-induced mouse ear oedema and inhibition by prednisolone","volume":"44","author":"Towbin","year":"1995","journal-title":"Inflamm Res"},{"key":"10.1016\/j.intimp.2008.06.009_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.118.2.503","article-title":"Proinflammatory cytokines","volume":"118","author":"Charles","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2008.06.009_bib28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.275.5302.977","article-title":"Immunoglobin E production in the absence of interleukin-4-secreting CD1 dependent cells","volume":"275","author":"Smiley","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.intimp.2008.06.009_bib29","first-page":"3237","article-title":"Preventive effect of hesperidin against inflammation in CD-1 mice skin caused by tumor promoter","volume":"19","author":"Koyuncu","year":"1999","journal-title":"Anticancer research"},{"key":"10.1016\/j.intimp.2008.06.009_bib30","first-page":"12","article-title":"Epidermal anti-inflammatory properties of 5, 11, 14, 20:3: effects on mouse ear edema, PGE2 levels in cultured keratinocytes and PPAR activation","volume":"1","author":"Berger","year":"2002","journal-title":"Lipids Health Dis"},{"issue":"6","key":"10.1016\/j.intimp.2008.06.009_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11745-003-1104-y","article-title":"Antagonism of croton oil inflammation by topical emu oil in CD-1 mice","volume":"38","author":"Yoganathan","year":"2003","journal-title":"Lipids"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2008.06.009_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2005.04.035","article-title":"Self-association properties of 4-[1-hydroxy-1-methylethyl]-2-propyl-1-[4-[2-[tetrazole-5-yl] phenyl]phenyl] methylimidazole-5-carboxylic acid monohydrate (CS-088), an antiglaucoma ophthalmic agent","volume":"299","author":"Kikuchi","year":"2005","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.intimp.2008.06.009_bib33","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/jps.21182","article-title":"Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations","volume":"97","author":"Desai","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.intimp.2008.06.009_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2006.07.027","article-title":"Enhancement of transdermal delivery of theophylline using microemulsion vehicle","volume":"327","author":"Zhao","year":"2006","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.intimp.2008.06.009_bib35","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.2460\/ajvr.1999.60.12.1558","article-title":"Effect of emu oil on auricular inflammation induced with croton oil in mice","volume":"60","author":"Lopez","year":"1999","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.intimp.2008.06.009_bib36","doi-asserted-by":"crossref","first-page":"10640","DOI":"10.1021\/ja039651w","article-title":"Supramolecular assemblies based on co polymers of PEG 600 and functionalized aromatic diesters for drug delivery applications","volume":"126","author":"Kumar","year":"2004","journal-title":"J Am Chem Soc"},{"issue":"9\u201310","key":"10.1016\/j.intimp.2008.06.009_bib37","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1166\/jnn.2006.483","article-title":"Novel drug delivery system by surface modified magnetic nanoparticles","volume":"6","author":"Takeda","year":"2006","journal-title":"J Nanosci Nanotechnol."},{"issue":"9\u201310","key":"10.1016\/j.intimp.2008.06.009_bib38","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1166\/jnn.2006.436","article-title":"SiRNA drug delivery by biodegradable polymeric nanoparticles","volume":"6","author":"Yuan","year":"2006","journal-title":"J Nanosci Nanotechnol."},{"issue":"5","key":"10.1016\/j.intimp.2008.06.009_bib39","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biomaterials.2006.09.047","article-title":"Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery","volume":"28","author":"Cheng","year":"2007","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.intimp.2008.06.009_bib40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1024474609667","article-title":"Improving relative bioavailability of dicumarol by reducing particle size and adding the adhesive poly (fumaric-co-sebacic) anhydride","volume":"20","author":"Thanos","year":"2003","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2008.06.009_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2004.09.002","article-title":"PLA-PEG particles as nasal protein carriers: the influence of the particle size","volume":"292","author":"Vila","year":"2005","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2008.06.009_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-5173(01)00671-8","article-title":"Topical transport of hydrophilic compounds using water-in-oil nanoemulsions","volume":"220","author":"Wu","year":"2001","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.intimp.2008.06.009_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156720105774370267","article-title":"Engineering of nanoemulsions for drug delivery","volume":"2","author":"Sarker","year":"2005","journal-title":"Curr Drug Deliv."},{"key":"10.1016\/j.intimp.2008.06.009_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2006.10.014","article-title":"Development and bioavailability assessment of ramipril nanoemulsion formulation","volume":"66","author":"Shafiq","year":"2007","journal-title":"Eur J Pharm BioPharm"},{"key":"10.1016\/j.intimp.2008.06.009_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.jid.5700485","article-title":"Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats","volume":"127","author":"Khandavilli","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.intimp.2008.06.009_bib46","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.intimp.2008.06.009_bib47","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.ATV.0000022695.22369.BE","article-title":"Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells","volume":"22","author":"Tiran","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908001859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908001859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T01:18:04Z","timestamp":1738286284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576908001859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1567576908001859"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2008.06.009","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}